Frost, B., Valtis, Y., Flamand, Y., Baxter, E., Nemirovsky, D., Derkach, A., Chin, K., Salman, M. Y., Boussi, L., Ovalle, N. T., Stein, E., Geyer, M., Shimony, S., Garcia, J., Wadleigh, M., Winer, E., Volpe, V., Stahl, M., Stone, R., Deangelo, D., Park, J., Luskin, M., Chen, E. (2025). Prognosis in adults with ph-positive B-ALL in first complete remission without minimal residual disease after blinatumomab consolidation is influenced by minimal residual disease (≥10-4) pre-blinatumomab. Blood. https://doi.org/10.1182/blood-2025-3329